BDH2
BDH2 (3-hydroxybutyrate dehydrogenase 2, also known as DHRS6, SDR15C1 and UCPA-OR) is a cytoplasmic NAD(H)-dependent dehydrogenase/reductase of the short-chain dehydrogenase/reductase superfamily. It contributes to siderophore-mediated iron handling and to the detoxification of ketoprolines. Browse Assay Genie's current range of BDH2 research reagents below, or read on for the biology behind the target.
BDH2 is an NAD(H)-dependent dehydrogenase/reductase with a preference for cyclic substrates. It catalyses the stereoselective conversion of 4-oxo-L-proline to cis-4-hydroxy-L-proline, which is likely a detoxification mechanism for ketoprolines. It also mediates formation of 2,5-dihydroxybenzoate (2,5-DHBA), a siderophore that chelates free cytoplasmic iron and associates with LCN2. In this way BDH2 regulates iron transport and homeostasis and helps protect cells against free radical-induced oxidative stress.
The iron-siderophore complex is imported into mitochondria, where it provides an iron source for mitochondrial metabolic processes, in particular heme synthesis. BDH2 may also act as a 3-hydroxybutyrate dehydrogenase. NCBI Gene annotation lists 3-hydroxybutyrate dehydrogenase activity and NAD binding, places the protein in the cytosol, and links it to epithelial cell differentiation and fatty acid beta-oxidation.
The BDH2 gene encodes a member of the short-chain dehydrogenases/reductases (SDR) family, and HGNC classes it in the short chain dehydrogenase/reductase superfamily. Its previous names include dehydrogenase/reductase (SDR family) member 6 and 3-hydroxybutyrate dehydrogenase, type 2, which explains the aliases DHRS6 and SDR15C1. Orthologues are annotated in mouse and rat as Bdh2. The related enzyme BDH1 shares the 3-hydroxybutyrate dehydrogenase name.
BDH2 produces the 2,5-DHBA siderophore that chelates cytoplasmic iron and associates with LCN2, making it a focus for studies of iron transport.
The iron-siderophore complex is imported into mitochondria as an iron source, linking BDH2 to heme synthesis and mitochondrial metabolism.
By sequestering free iron, BDH2 helps protect cells against free radical-induced oxidative stress.
BDH2 may act as a 3-hydroxybutyrate dehydrogenase and is annotated in fatty acid beta-oxidation, relevant to metabolic enzymology.
BDH2 is an NAD(H)-dependent dehydrogenase/reductase that converts 4-oxo-L-proline to cis-4-hydroxy-L-proline and mediates synthesis of the siderophore 2,5-DHBA. This siderophore chelates cytoplasmic iron and supports iron homeostasis, including mitochondrial heme synthesis. It may also act as a 3-hydroxybutyrate dehydrogenase.
BDH2 is also called DHRS6, SDR15C1, UCPA-OR, FLJ13261, UNQ6308 and PRO20933. UniProt names the protein dehydrogenase/reductase SDR family member 6. Earlier HGNC names were dehydrogenase/reductase (SDR family) member 6 and 3-hydroxybutyrate dehydrogenase, type 2.
Yes. Mouse and rat both carry a Bdh2 orthologue, so rodent models can be used to study its role. BDH2 belongs to the widely distributed short-chain dehydrogenase/reductase family. Check the datasheet of any product for its validated reactivity.
BDH1, a related 3-hydroxybutyrate dehydrogenase, and LCN2, a siderophore partner, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9BUT1; product specifications from Assay Genie datasheets.